Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bear bile chuanbei oral liquid is a Traditional Chinese Medicine (TCM) formulation developed and marketed by Pharmesis International. It is primarily indicated for the relief of cough and the resolution of phlegm, particularly in conditions associated with 'lung heat' such as acute or chronic bronchitis. The product is a combination of bear bile powder and Fritillaria cirrhosa (Chuanbei). Bear bile is traditionally valued for its anti-inflammatory and antitussive properties, often attributed to bile acids like tauroursodeoxycholic acid (TUDCA). Fritillaria cirrhosa is a staple herb in TCM used to moisten the lungs and clear heat. The product is approved and marketed as an over-the-counter (OTC) medication in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bear bile chuanbei oral liquid.